20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VANCOMYCIN HYDROCHLORIDE USP, with a corresponding US DMF Number 22528.
Remarkably, this DMF maintains an Active status since its submission on February 10, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2017, and payment made on December 19, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II